Cargando…

An Activating Transcription Factor 5-Mediated Survival Pathway as a Target for Cancer Therapy

Genes that are highly expressed in cancer cells and are essential for their viability are attractive targets for the development of novel cancer therapeutics. Activating transcription factor 5 (ATF5) is an anti-apoptotic protein that is highly expressed in malignant glioma but not normal brain tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Zhi, Evans, Sara K., Green, Michael R.
Formato:	Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2010
Materias:	Research Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069685/ https://www.ncbi.nlm.nih.gov/pubmed/21311102

Ejemplares similares

Indirect Mechanisms of Transcription Factor‐Mediated Gene Regulation during Cell Fate Changes
por: Larcombe, Michael R., et al.
Publicado: (2022)

Targeting immunometabolic pathways for combination therapy in Alzheimer's disease
por: Erichsen, Jennifer, et al.
Publicado: (2023)

Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
por: Wang, Yi-Ting, et al.
Publicado: (2023)

Targeting splicing factors for cancer therapy
por: Bashari, Ariel, et al.
Publicado: (2023)

Targeting AP-1 transcription factors by CRISPR in the prostate
por: Riedel, Maria, et al.
Publicado: (2021)

FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020)

Transcriptional Robustness Complements Nonsense-Mediated Decay in Humans
por: Wilke, Claus O.
Publicado: (2011)

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
por: Berghella, Anna Maria, et al.
Publicado: (2011)

CLDN18.2-targeted molecular imaging and precision therapy of gastrointestinal tumors
por: Chen, Yan, et al.
Publicado: (2023)

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments
por: Miranda, Mariska, et al.
Publicado: (2015)

PPAR-γ: a thrifty transcription factor
por: Auwerx, Johan, et al.
Publicado: (2003)

Onecut transcription factors in retinal development and maintenance
por: Sapkota, Darshan, et al.
Publicado: (2015)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

The transcription factor activity gradient (TAG) model: contemplating a contact-independent mechanism for enhancer–promoter communication
por: Karr, Jonathan P., et al.
Publicado: (2022)

Fortuitous benefits of activity-based rehabilitation in stem cell-based therapy for spinal cord repair: enhancing graft survival
por: Hwang, Dong Hoon, et al.
Publicado: (2015)

Noncanonical binding of transcription factors: time to revisit specificity?
por: Samee, Md. Abul Hassan
Publicado: (2023)

Targeting MET in cancer therapy
por: Mo, Hong-Nan, et al.
Publicado: (2017)

Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death
por: Doti, Nunzianna, et al.
Publicado: (2017)

Engineering personalized neural tissue using functionalized transcription factors
por: Willerth, Stephanie M.
Publicado: (2016)

Maternal or zygotic: Unveiling the secrets of the Pancrustacea transcription factor zelda
por: Nunes da Fonseca, Rodrigo, et al.
Publicado: (2018)

Challenges of Decoding Transcription Factor Dynamics in Terms of Gene Regulation
por: Martin, Erik W., et al.
Publicado: (2018)

Genetically modifying transcription factors to promote CNS axon regeneration
por: Mehta, Saloni T., et al.
Publicado: (2017)

Progress in targeted therapy for breast cancer
por: Ju, Jie, et al.
Publicado: (2018)

The inositol metabolism pathway as a target for neuroprotective strategies
por: Nystuen, Arne M., et al.
Publicado: (2015)

Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016)

Transcription factors promote neural regeneration after spinal cord injury
por: Finkel, Zachary, et al.
Publicado: (2022)

Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy
por: Donnelly, Ryan F., et al.
Publicado: (2007)

Origins and Consequences of Chromosomal Instability: From Cellular Adaptation to Genome Chaos-Mediated System Survival
por: Ye, Christine J., et al.
Publicado: (2020)

Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
por: Stoddart, Angela, et al.
Publicado: (2011)

Initiating head development in mouse embryos: integrating signalling and transcriptional activity
por: Arkell, Ruth M., et al.
Publicado: (2012)

Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies
por: Yamaguchi, Ryuji, et al.
Publicado: (2017)

Recent advances in RNA-targeting therapy for neurological diseases
por: Kumar, Satheesh, et al.
Publicado: (2023)

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma
por: Desai, Omkar, et al.
Publicado: (2023)

The Impact of the “Yogic Lifestyle” on Cancer Prognosis and Survival: Can we Target Cancer Stem Cells with Yoga?
por: Beri, Kavita
Publicado: (2017)

A Transcriptional Signature for Active TB: Have We Found the Needle in the Haystack?
por: Cattamanchi, Adithya, et al.
Publicado: (2013)

Are circulating endothelial cells the next target for transcriptome-level pathway analysis in ARDS?
por: Costa Monteiro, Ana C., et al.
Publicado: (2023)

Lingo-1: a novel target in therapy for Alzheimer's disease?
por: Fernandez-Enright, Francesca, et al.
Publicado: (2016)

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
por: Jia, Hongpeng, et al.
Publicado: (2021)

The new wave of p75 neurotrophin receptor targeted therapies
por: Crooks, Amanda M., et al.
Publicado: (2021)

Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy
por: Zheng, Pan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_etbmvm21dm8r7biue731sobu1h